Table.
Antibiotic consumption estimates by GBD super-region and GBD region, for the year 2018
| Volume of total antibiotic consumption (Million DDD, 95%UI) | Global antibiotic consumption | Rate of total antibiotic consumption (DDD per 1000 per day, 95% UI) | ||
|---|---|---|---|---|
| Southeast Asia, east Asia, and Oceania | ||||
| Super-region estimate | 7048 (6717–7437)* | 17·5% | 9·0 (8·5–9·5)* | |
| East Asia | 4413 (4383–4454)* | 11·0% | 8·2 (8·2–8·3)* | |
| Southeast Asia | 2592 (2305–2926) | 6·5% | 10·6 (9·4–12·0) | |
| Oceania | 42 (29–57) | 0·1% | 9·3 (6·5–12·6) | |
| Central Europe, eastern Europe, and central Asia | ||||
| Super-region estimate | 2525 (2333–2752)* | 6·3% | 16·5 (15·3–18·0) | |
| Central Asia | 546 (433–682) | 1·4% | 16·2 (12·8–20·2) | |
| Central Europe | 951 (922–984) | 2·4% | 22·5 (21·8–23·3) | |
| Eastern Europe | 1028 (977–1086)* | 2·6% | 13·4 (12·8–14·2)* | |
| High income | ||||
| Super-region estimate | 8196* | 20·4% | 20·8* | |
| High-income Asia-Pacific | 1142* | 2·8% | 16·7* | |
| Australasia | 257* | 0·6% | 24·5* | |
| Western Europe | 3364* | 8·4% | 21·1* | |
| Southern Latin America | 342* | 0·9% | 14·2* | |
| High-income North America | 3092* | 7·7% | 23·4* | |
| Latin America and Caribbean | ||||
| Super-region estimate | 2477 (2226–2758) | 6·2% | 11·6 (10·5–13·0) | |
| Caribbean | 166 (135–207) | 0·4% | 10·2 (8·3–12·7) | |
| Andean Latin America | 319 (296–343) | 0·8% | 13·6 (12·6–14·6) | |
| Central Latin America | 792 (733–856) | 2·0% | 8·5 (7·8–9·1) | |
| Tropical Latin America | 1200 (1062–1352) | 3·0% | 15·1 (13·4–17) | |
| North Africa and Middle East | ||||
| Super-region estimate | 5229 (4515–6095) | 13·0% | 23·6 (20·4–27·5) | |
| South Asia | ||||
| Super-region estimate | 10 104 (9650–10 598) | 25·2% | 15·5 (14·8–16·2) | |
| Sub-Saharan Africa | ||||
| Super-region estimate | 4586 (3564–5905) | 11·4% | 11·8 (9·2–15·2) | |
| Central sub-Saharan Africa | 387 (276–533) | 1·0% | 8·2 (5·9–11·3) | |
| Eastern sub-Saharan Africa | 1788 (1374–2324) | 4·5% | 12·2 (9·4–15·9) | |
| Southern sub-Saharan Africa | 445 (391–509) | 1·1% | 15·6 (13·7–17·9) | |
| Western sub-Saharan Africa | 1966 (1524–2538) | 4·9% | 11·9 (9·2–15·4) | |
| Global | 40 165 (37 200–43 740)* | 100·0% | 14·3 (13·2–15·6)* | |
Data are DDD (95% UI) or %. DDD=defined daily doses. GBD=Global Burden of Disease. UI=uncertainty interval.
*
UIs were not estimated for high-income countries, Russia, Lebanon, and China.